Tag Archives: BMO Capital Markets

BMO Reduced Its Recommendation of BOK Financial

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Annie Barr

BMO Reduced Its Recommendation of BOK Financial.

Mattel Has Been Downgraded by analysts

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Jared Haas

Mattel, Inc. (MAT) price target has been reduced from $40 to $33 a share.

Top